Perceptive Advisors is a hedge fund sponsor with a strong focus on the life sciences sector, investing in promising healthcare technologies. The firm typically participates in various investment stages, including Series A, B, C, and later rounds, with a significant number of investments in Series B and C rounds. Their investment strategy is centered on identifying and supporting breakthrough innovations in healthcare that have the potential to make a substantial impact on the industry.
Notable portfolio companies include 4D Molecular Therapeutics, Absci, Alector, Beam Therapeutics, and BridgeBio Pharma. The firm is led by a skilled team with deep expertise in the biomedical landscape, guiding companies from discovery to distribution. Perceptive Advisors offers unique value-add services, leveraging their extensive industry knowledge and network to support the growth and success of their portfolio companies. Their investment philosophy emphasizes long-term potential and transformative impact in the healthcare sector.
Perceptive Advisors - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Perceptive: A hedge fund sponsor investing in promising healthcare technologies to advance life sciences.
Stage Mix
Concentration shown as share of disclosed investments by stage.
Perceptive Life Sciences
Perceptive Equity
Perseus-Soros Biopharmaceutical Fund
OrbiMed Advisors
orbimed.com
Pappas Capital
pappas-capital.com
Percipient Capital
PFM Health Sciences
Helicase Venture
Biospring Partners
biospring.com
Avoro Capital Advisors
avorocapital.com
Mirae Asset Capital Life Science
Perceptive Ventures
perceptivevc.com
Pivotal bioVenture Partners
Octagon Capital Advisors
Endpoint Ventures
endpoint.vc
